These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8618513)

  • 21. Informed consent in neonatal randomised trials.
    Koh TH; Collie L; Budge D; Butow P
    Lancet; 2001 May; 357(9266):1445-6. PubMed ID: 11360948
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant erythropoietin in anemia of prematurity: five years later.
    Shannon K
    Pediatrics; 1993 Oct; 92(4):614-7. PubMed ID: 8414840
    [No Abstract]   [Full Text] [Related]  

  • 23. Foreseeable risks? Informed consent for studies within the standard of care.
    Sacks CA; Warren CE
    N Engl J Med; 2015 Jan; 372(4):306-7. PubMed ID: 25517574
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant erythropoietin in very-low-birth-weight infants.
    van den Anker JN; Montini G; Carnielli VP
    N Engl J Med; 1994 Sep; 331(10):677; author reply 677-8. PubMed ID: 8093178
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence based care.
    Brocklehurst P; McGuire W
    BMJ; 2005 Jan; 330(7481):36-8. PubMed ID: 15626805
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant erythropoietin and blood transfusion in selected preterm infants.
    Meyer MP; Sharma E; Carsons M
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F41-5. PubMed ID: 12496225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin and preemies.
    Meyer MP
    Pediatrics; 2002 Dec; 110(6):1253-5; author reply 1253-5. PubMed ID: 12456927
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhaled nitric oxide for preterm infants: a therapy in search of an indication? The search continues.
    Finer NN
    J Pediatr; 2005 Mar; 146(3):301-3. PubMed ID: 15756205
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigating allegations of research misconduct: the vital need for due process.
    Hey E; Chalmers I
    BMJ; 2000 Sep; 321(7263):752-5. PubMed ID: 10999913
    [No Abstract]   [Full Text] [Related]  

  • 30. Viability of infants born at 22 to 25 weeks' gestation.
    Clark F
    N Engl J Med; 1994 Apr; 330(17):1235; author reply 1235-6. PubMed ID: 8139638
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized, placebo-controlled clinical trial of recombinant human erythropoietin in the anemia of prematurity.
    Mentzer WC; Shannon KM; Abels RI; Freeman P; Newton N; Thompson D; Phibbs RH
    Contrib Nephrol; 1991; 88():306-12; discussion 313. PubMed ID: 2040193
    [No Abstract]   [Full Text] [Related]  

  • 32. Informed consent: influence on patient selection among critically ill premature infants.
    Walterspiel JN
    Pediatrics; 1990 Jan; 85(1):119-21. PubMed ID: 2296479
    [No Abstract]   [Full Text] [Related]  

  • 33. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony-stimulating factor for treatment of the anemia of prematurity.
    Christensen RD; Hunter DD; Ohls RK
    J Perinatol; 1994; 14(2):110-3. PubMed ID: 8014692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethics of consent for babies in randomised clinical trials.
    Meran JG
    Lancet; 1995 May; 345(8961):1370. PubMed ID: 7752778
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity.
    Pathak A; Roth P; Piscitelli J; Johnson L
    Arch Dis Child Fetal Neonatal Ed; 2003 Jul; 88(4):F324-8. PubMed ID: 12819167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dosing with recombinant human erythropoietin, used for treating early anemia of premature infants].
    Rabbani F
    Lik Sprava; 2002; (3-4):81-4. PubMed ID: 12145901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic growth factors: Part II.
    Wandstrat TL; Wolfe M
    Neonatal Netw; 1996 Oct; 15(7):25-8. PubMed ID: 9035641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SUPPORT controversy and learnings.
    Bandewar SV
    Indian J Med Ethics; 2015; 12(1):18-24. PubMed ID: 25376922
    [No Abstract]   [Full Text] [Related]  

  • 40. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
    Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
    Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.